Navigation Links
Trovagene to Present at Two Healthcare Conferences
Date:9/4/2013

ed for 90 days.

About Trovagene, Inc.Headquartered in San Diego, California, Trovagene is leveraging its patented technology for the detection of cell-free DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that can be isolated and detected from urine. Trovagene has a strong intellectual property asset as it relates to cell-free DNA and RNA testing in urine. It has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or fourth party payer reimbursement; limited sales and marketing efforts and dependence upon fourth parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially s
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trovagene to Present at Leerink Swan Global Healthcare Conference
2. Trovagene to be Added to Russell Microcap Index
3. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
4. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
5. TrovaGene Acquires CLIA - Certified Laboratory
6. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
7. Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference
8. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
9. ANP to present at and attend major US investment, partnering and industry conferences
10. Cambridge Semantics to Present on ‘Smart Data’ During Deep-Dive Workshop at 2013 Big Data Innovation Summit
11. EnduRx Pharmaceuticals to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... On September 11, Pharma IQ conducted an interview with ... session that he will lead on “Stem Cells” at the ... 2015 in London. In the interview posted online ... respond to several questions on the current state of technologies ... toxicity, and future trends in the use of stem cells ...
(Date:9/29/2014)... 2014 Each year in the ... medical attention. In the military, burn injury is ... battlefield medical care. More than 800 service members ... wounds heal slowly, remain inflamed and often become ... debilitating and functionally damaging. While developments in supportive ...
(Date:9/29/2014)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... that its three Promissory Note holders, two of whom ... each in July 2014 for a total of $ ... converted into 3,500,001 restricted common shares. Notes were repayable ... Note and the coupon were convertible into common shares ...
(Date:9/29/2014)... Transparency Market Research, in its report ... HPPS, by Application - Cancer, Metabolic, CVS, CNS & ... Delivery) - Global Industry Analysis, Size, Share, Growth, Trends ... peptide therapeutics market was worth US$14.1 billion in 2011 ... at an 8.7% CAGR. , The two main types ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4Faster Healing with Fewer Scars 2Portage announces conversion of its debt into equity 2Portage announces conversion of its debt into equity 3Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3
... , , , , , , ... DNA per 450 l of supernatant processed. PLG tubes , also can be used ... , Grow a 10 ml stock of ... 0.5% yeast extract, 0.5% NaCl, 1 mM MgSO4, pH 7.5) overnight , ...
... , , , , , ... Katherine A. Borkovich PhD, University of Texas-Houston Medical Center, , ... and Molecular Genetics, Houston, Texas. , Kimberly Vollmer, Brinkmann™ ... , , , , , ...
... , , , Disposables such as ... to chemical reactions and they must withstand the various kinds , ... , and autoclaving). The stability level of these products ... they are made and this material's processing , during ...
Cached Biology Technology:Lambda DNA Extraction Protocol 2Efficient Transfection of Neurospora Crassa 2Efficient Transfection of Neurospora Crassa 3Efficient Transfection of Neurospora Crassa 4Efficient Transfection of Neurospora Crassa 5Chemical Stability of Disposables 2Chemical Stability of Disposables 3Chemical Stability of Disposables 4Chemical Stability of Disposables 5Chemical Stability of Disposables 6Chemical Stability of Disposables 7Chemical Stability of Disposables 8Chemical Stability of Disposables 9Chemical Stability of Disposables 10Chemical Stability of Disposables 11Chemical Stability of Disposables 12Chemical Stability of Disposables 13Chemical Stability of Disposables 14Chemical Stability of Disposables 15Chemical Stability of Disposables 16Chemical Stability of Disposables 17Chemical Stability of Disposables 18Chemical Stability of Disposables 19Chemical Stability of Disposables 20Chemical Stability of Disposables 21Chemical Stability of Disposables 22Chemical Stability of Disposables 23Chemical Stability of Disposables 24Chemical Stability of Disposables 25Chemical Stability of Disposables 26Chemical Stability of Disposables 27Chemical Stability of Disposables 28Chemical Stability of Disposables 29Chemical Stability of Disposables 30Chemical Stability of Disposables 31
(Date:9/29/2014)... Oktoberfest is here, and that means ... for a cold one, taking that first ... chemicals have reacted to form compounds that ... Reactions explains why beers get skunky, and ... brews from going bad. Learn all about ...
(Date:9/29/2014)... available in French . ... number of days an expectant mother was deprived of ... profile of her child, a new study finds., Scientists ... University have detected a distinctive ,signature, in the DNA ... Quebec ice storm. Five months after the event, researchers ...
(Date:9/29/2014)... researchers at the University of Cambridge has shown that ... most of Greenland is more sensitive to climate change ... rising sea levels that threaten coastal communities worldwide. , ... levels of meltwater created and spilled into the ocean ... new model also takes into account the role that ...
Breaking Biology News(10 mins):Greenland Ice Sheet more vulnerable to climate change than previously thought 2Greenland Ice Sheet more vulnerable to climate change than previously thought 3
... campus of The Scripps Research Institute have uncovered a ... cell death, a characteristic of neurodegenerative diseases such as ... In the study, published recently in the journal ... could disrupt a specific interaction of a critical enzyme ...
... A multicenter clinical trial led by a researcher at ... Center will evaluate a new approach to treat triple-negative ... more common among African-Americans and young women. The study ... can reprogram tumor cells to express a protein called ...
... A new study concludes that models may be ... too high or too low, depending on the region, ... affect the amount of carbon released from soil. ... estimates of greenhouse gas emissions from soils based on ...
Cached Biology News:Scripps Research scientists find way to block stress-related cell death 2New clinical trial to test novel approach to treat triple-negative breast cancer 2New clinical trial to test novel approach to treat triple-negative breast cancer 3Climate projections don't accurately reflect soil carbon release 2Climate projections don't accurately reflect soil carbon release 3
NATIVE, ENZYME PORCINE TRYPSIN...
See product name for description....
Mycoplasma tested...
... Cloning Checker Kits provide two highly efficient ... without time-consuming plasmid preparation. By using the ... you need to do is to transfer ... from the transformation plates into the solutions ...
Biology Products: